EFFICACY OF IFOSFAMIDE IN REFRACTORY MALIGNANT DISEASES AND UROPROTECTION BY MESNA - RESULTS OF A CLINICAL-PHASE II-STUDY WITH 151 PATIENTS

被引：79

作者：

SCHEULEN, ME

NIEDERLE, N

BREMER, K

SCHUTTE, J

SEEBER, S

机构：

来源：

CANCER TREATMENT REVIEWS | 1983年 / 10卷

关键词：

D O I：

10.1016/S0305-7372(83)80013-9

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：93 / 101

页数：9

共 20 条

[1] CHEMOTHERAPY IN ADVANCED SARCOMAS [J].

BIERBAUM, W ;

BREMER, K ;

FIRUSIAN, N ;

HIGI, M ;

NIEDERLE, N ;

SCHEULEN, ME ;

SCHMIDT, CG ;

SEEBER, S .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1981, 106 (37) :1181-&

[2] ETOPOSIDE AND ETOPOSIDE IFOSFAMIDE THERAPY FOR REFRACTORY TESTICULAR-TUMORS [J].

BREMER, K ;

NIEDERLE, N ;

KRISCHKE, W ;

HIGI, M ;

SCHEULEN, ME ;

SCHMIDT, CG ;

SEEBER, S .

CANCER TREATMENT REVIEWS, 1982, 9 :79-84

[3]

BREMNER DN, 1974, CANCER CHEMOTH REP 1, V58, P889

[4]

BROCK N, 1979, ARZNEIMITTEL-FORSCH, V29-1, P659

[5] DETOXIFICATION OF UROTOXIC OXAZAPHOSPHORINES BY SULFHYDRYL COMPOUNDS [J].

BROCK, N ;

POHL, J ;

STEKAR, J .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1981, 100 (03) :311-320

[6]

BROCK N, 1972, ADV ANTIMICROBIAL AN, V2, P749

[7] PROPHYLACTIC ALKALINIZATION OF URINE IN CYTOSTATIC TUMOR-THERAPY WITH THE OXAZAPHOSPHORINE DERIVATES CYCLOPHOSPHAMIDE AND IFOSFAMIDE [J].

BRUHL, P ;

HOEFERJANKER, H ;

SCHEEF, W ;

VAHLENSIECK, W .

ONKOLOGIE, 1979, 2 (03) :120-124

[8]

CONSTANZI JJ, 1978, CANCER, V41, P1715

[9]

GOLDIE JH, 1982, CANCER TREAT REP, V66, P439

[10]

GOTTLIEB JA, 1975, CANCER CHEMOTH REP 3, V6, P271

← 1 2 →